openPR Logo
Press release

In Vivo CRO Market worth $8.56 billion by 2030, growing at a CAGR of 9.68% - Exclusive Report by 360iResearch

10-05-2023 11:34 AM CET | Health & Medicine

Press release from: 360iResearch

In Vivo CRO Market | 360iResearch

In Vivo CRO Market | 360iResearch

The "In Vivo CRO Market by Type (Non-Rodent, Rodent), GLP Type (GLP Toxicology, Non-GLP), Indication - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.

Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/in-vivo-cro?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Market Segmentation & Coverage:

This research report categorizes the In Vivo CRO Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Non-Rodent and Rodent. The Rodent is further studied across Mice and Rats. The Rodent is projected to witness significant market share during forecast period.

Based on GLP Type, market is studied across GLP Toxicology and Non-GLP. The GLP Toxicology is further studied across In House and Outsourcing. The Non-GLP is further studied across In House and Outsourcing. The GLP Toxicology is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Autoimmune/inflammation conditions, Blood Cancer, CNS conditions, Diabetes, Obesity, Oncology, Pain management, and Solid Tumor. The Autoimmune/inflammation conditions is further studied across Irritable Bowel Syndrome, Multiple Sclerosis, Osteoarthritis, and Rheumatoid Arthritis. The CNS conditions is further studied across ALS, Epilepsy, Huntington's Disease, Muscle Regeneration, Parkinson's Disease, Stroke, and Traumatic Brain Injury. The Pain management is further studied across Acute Pain and Chronic Pain. The Solid Tumor is further studied across Patient-derived Xenograft, Syngeneic Model, and Xenograft. The Blood Cancer is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the In Vivo CRO Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the In Vivo CRO Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the In Vivo CRO Market, highlighting leading vendors and their innovative profiles. These include Charles River Laboratories, Crown Bioscience, Inc., Eurofins Scientific SE, Evotec SE, ICON Plc, Labcorp Drug Development, Medpace, Inc., MI Bioresearch, Inc., Parexel International Corporation, Pharmacology Discovery Services, PPD Inc., Syneos Health, Syngene International Limited, Taconic Biosciences, Inc., and WuXi AppTec, Inc..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. In Vivo CRO Market, by Type
7. In Vivo CRO Market, by GLP Type
8. In Vivo CRO Market, by Indication
9. Americas In Vivo CRO Market
10. Asia-Pacific In Vivo CRO Market
11. Europe, Middle East & Africa In Vivo CRO Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the In Vivo CRO Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the In Vivo CRO Market?
3. What is the competitive strategic window for opportunities in the In Vivo CRO Market?
4. What are the technology trends and regulatory frameworks in the In Vivo CRO Market?
5. What is the market share of the leading vendors in the In Vivo CRO Market?
6. What modes and strategic moves are considered suitable for entering the In Vivo CRO Market?

Read More @ https://www.360iresearch.com/library/intelligence/in-vivo-cro?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Vivo CRO Market worth $8.56 billion by 2030, growing at a CAGR of 9.68% - Exclusive Report by 360iResearch here

News-ID: 3236176 • Views:

More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Global Treatment Demand
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and expected to reach USD 10.06 billion in 2024, at a CAGR 7.63% to reach USD 15.71 billion by 2030.
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 2023 and expected to reach USD 292.84 billion in 2024, at a CAGR 11.08% to reach USD 552.63 billion by 2030.
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 and expected to reach USD 62.23 billion in 2024, at a CAGR 9.99% to reach USD 110.34 billion by 2030.
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital

All 5 Releases


More Releases for Vivo

Vivo City: Redefining Luxury Living in Nelamangala
Nelamangala's [Bangalore] transformation is fuelled by its strategic location and enhanced connectivity. Simultaneously, the relative affordability of land compared to Bengaluru's core districts has spurred significant residential development. This influx of infrastructure and population has created a dynamic real estate market ripe for innovative projects. SJR Vivo City is positioned to capitalize on this growth, offering a distinct vision of luxury living that caters to the aspirations of modern homebuyers.
In Vivo Toxicology Market
The global in vivo toxicology market is anticipated to grow at a significant CAGR of over 4% during the forecast period. The increasing investments for R&D are one of the major driving factors for the in vivo toxicology market. The researchers are investing in huge amounts of drugs in the initial levels to reduce the risks of its failure during the later expensive levels of trials. This reduces time consumption
In Vivo Imaging Systems Market 2022 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the In Vivo Imaging Systems industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The In Vivo Imaging Systems market survey report has been prepared by conducting market research in a systematic manner. Moreover, the In Vivo Imaging Systems
In Vivo Imaging Systems Market 2022 | Detailed Report
The In Vivo Imaging Systems research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the
IntraSense – world's smallest in-vivo pressure sensor for catheter
AMSYS GmbH & Co. KG, November 2021 - With the IntraSense, AMSYS presents the smallest in-vivo pressure sensor for integration into catheters with only 1 French diameter. Measuring only 750 μm × 220 μm × 75 μm, the sensor already has a highly flexible, fully protected cable connected for ease of use. The sensor is designed to operate in air and saline fluids such as blood, cerebro-spinal fluid or urine.
Ex-Vivo Organ Perfusion Market - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Ex-Vivo Organ Perfusion Market is projected to grow at a CAGR value of around 7.2% during the forecast period [2021 to 2026]. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Ex-Vivo Organ Perfusion Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/ex-vivo-organ-perfusion-market-3460 By Perfusion Technology (Hypothermic Perfusion Technology and Normothermic